Come up with a name for your new list and we'll add to it:
Monarch Bioimplants raised a round of funding on July 21, 2017. Investors include
Fast Track VC.
Monarch Bioimplants, based in Switzerland, has engineered a chitosan-based medical device that greatly reduces the incidence of impotence following a radical prostatectomy, a surgery that removes the …